CAS 1252927-47-1

5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide

Description:

The chemical substance known as 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, with the CAS number 1252927-47-1, is a sulfonamide compound characterized by its complex structure, which includes a sulfonamide group, a pyrimidine ring, and an indazole moiety. This compound typically exhibits properties associated with sulfonamides, such as potential antibacterial activity, although its specific biological activity may vary based on its structural features. The presence of multiple functional groups suggests that it may engage in various chemical interactions, making it a candidate for pharmaceutical applications. Its solubility, stability, and reactivity would depend on the specific conditions, including pH and solvent. Additionally, the compound's molecular weight and structural configuration contribute to its potential efficacy and safety profile in biological systems. As with many synthetic compounds, further studies would be necessary to fully elucidate its pharmacological properties and mechanisms of action.

Formula: C₂₀H₂₁N₇O₂S

Synonyms:

• Pazopanib Impurity 41
• Pazopanib N-Desmethyl Impurity
• 5-[[4-[(2,3-dimethylindazol-6-yl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide
• 5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide
• Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methyl-
• Pazopanib metabolite M27
• N-Demethyl Pazopanib
• Pazopanib metabolite M27 HCl
• GSK-1071306
• Pazopanib metabolite M27 Hydrochloride
• Pazopanib Impurity 13

Pazopanib Impurity 13

CAS: 1252927-47-1

Formula: C₂₀H₂₁N₇O₂S

Molecular weight: 423.50

Ref: 4Z-P-129022

GSK-1071306

CAS: 1252927-47-1

GSK-1071306 is a bio-active chemical.

Formula: C₂₀H₂₁N₇O₂S

Color and Shape: Solid

Molecular weight: 423.49

Ref: TM-T32000

N-Demethyl pazopanib

CAS: 1252927-47-1

N-Demethyl pazopanib is a synthetic drug that has been researched and developed for the treatment of cancer. It is an impurity standard, custom synthesis, and drug product. Synthetic N-demethyl pazopanib is used in clinical trials as a research and development tool to explore the metabolism of this drug and its metabolites. High purity N-demethyl pazopanib is used as a pharmacopoeia reference material for HPLC analysis in pharmacological studies. The metabolite of N-demethyl pazopanib has been found to be carcinogenic in animal studies. Metabolism studies have shown that N-demethyl pazopanib undergoes extensive hydroxylation and glucuronidation, which are detoxification pathways for xenobiotics in mammals.

Formula: C₂₀H₂₁N₇O₂S

Purity: Min. 95%

Molecular weight: 423.5 g/mol

Ref: 3D-CAC92747